Chinook Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Chinook Therapeutics

10/05/2023 22:01

* Chinook Therapeutics Inc  KDNY.OQ  reported a quarterly
adjusted
loss of 85 cents​​ per share for the quarter ended in March. The
mean expectation of ten analysts for the quarter was for a loss
of 79 cents per share.
    * Revenue fell 32.2% to $1.83 million from a year ago;
analysts
expected $240.00 thousand. 
    * Chinook Therapeutics Inc's reported EPS for the quarter
was a
loss of 85 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Chinook Therapeutics Inc shares had fallen by 7.0% this
quarter and lost 17.9% so far this year.
    * The company reported a quarterly loss of $60.18 million.
    * Wall Street's median 12-month price target for Chinook
Therapeutics Inc is $35.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 12 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.79          -0.85          Missed
 Dec. 31 2022      -0.79          -0.90          Missed
 Sep. 30 2022      -0.63          -0.83          Missed
 Jun. 30 2022      -0.61          -0.61          Met